We developed biomarker sensor and pioneered the use of non-invasive continuous glucose monitoring for diabetes management and dietary control. Current methods of measuring blood glucose primarily involve finger pricking or skin puncture, which still have drawbacks such as pain, short lifespan, high costs, limiting patient compliance, and generating medical waste. Therefore, we are currently developing proprietary AI algorithms to analyze ECG signals for estimating blood glucose levels and tracking trends through an APP. Non-invasive measurement can effectively increase user willingness, reduce expenses, and achieve better glucose management outcomes.